INTRODUCTION
============

Adhesive capsulitis is described as synovial hypertrophy and contraction,along with chronic inflammation of synovium with a relatively small amount of synovial fluid around the humeral head. More than 2% of the general population is known to have the disease; women over 50 years of age are more likely to present with this condition.[@B1],[@B2] Currently, several methods of treatment, such as physical therapy, pharmaceutical intervention, intra-articular injections, and exercise therapy are in clinical use, although the different methods show no differences in efficacy.[@B3]-[@B5] The capsular distension method has a therapeutic effect, via rupture of the stiffened capsule, by hydropressure.[@B6]

Under fluoroscopic guidance with contrast media injection, capsular distension was performed. After confirming the spinal needle\'s intra-articular placement in the articular cavity, contrast-mixed saline was injected until the pressure was sufficiently reduced to rupture the capsule. The rupture can be confirmed by the leakage of contrast media outside the capsule, and thisrupture usually takes place below the supscapular muscles and in the biceps\' tendon sheath. The success rate of the procedure is reported at 52-82%.[@B5]-[@B8]

Recently, ultra-sonography is more widely used in the diagnosis and treatment of musculoskeletal disease. The injection method, using a blind anatomical marker, when previously performed, had the limitation of delivering the drug into precisely the expected space. This method also leads to limitations in evaluating treatment efficacy. The X-ray guided injection method has the advantage of delivering drugs to the targeted space but the disadvantage of radiological exposure for both patients and clinicians. Additionally, this method can only be performed in a well-equipped healthcare service. On the other hand, ultra-sonography can be easily used in an outpatient setting, without the fear of radiological exposure.

Gam et al.[@B5] compared the efficacy of the capsular distension method with the glucocorticoid injection to glucocorticoid alone. Their results showed a definite improvement in range of motion along with the actual capsular distension seen in US.[@B5] However, few studies have been conducted to investigate the pros and cons of sono-guided capsular distension, compared with fluoroscopically guided capsular distension in patients. This study aims to evaluate this very issue.

MATERIALS AND METHODS
=====================

Study subjects
--------------

Patients visiting our rehabilitation outpatient department complainings of shoulder pain and limitation in motion, from January 2009 to June 2010, were initially selected. They were evaluated using a medical interview, physical exam, radiological exam, and musculoskeletal ultrasonography (US) in order to diagnose adhesive capsulitis. Among the patients diagnosed with adhesive capsulitis, 48 with remaining symptoms, after a 3 month-treatment period, were enrolled in the study. All patients were randomly assigned into two groups: group A for sono-guided capsular distension and group B for fluoroscopically guided capsular distension. Patients meeting study inclusion criteria[@B9]-[@B11] were those with 1 or 2 grade adhesive capsulitis, with symptom durations of 3 months to 2 years, or those with difficulties in two or more of the following: flexion, abduction, and/or external rotation presenting limitation of more than 30 degrees in passive and active ranges of motion, compared to the normal side with regard to range of motion. Exclusion criteria[@B9]-[@B11] encompassed the following: complete rotator cuff tear as seen with US, past traumatic shoulder injury requiring hospitalization in the prior 6 months, severe mental illness, age of less than 18 years or more than 70, degenerative arthritis in the shoulder (detected by radiological studies), systemic inflammatory disease, current use of anti-coagulant medications, diabetes mellitus, having known side effects with lidocaine or contrast media, and current infectious disease or suspected infection.

Method
------

### Randomization and injection frequency

After the acquisition of patients\' basic characteristics, participants went through one of two treatment modalities. The participants were assigned into two groups with the random block assignment method; patients were lined up to be assigned. Four patient-blocks were further subdivided into groups A and B, with the use of a 6 serial method: \'AABB, ABAB, BAAB, BABA, BBAA, ABBA\'. For every fourth participant, one method among 6 was randomly selected and assigned to that individual. Group A, under US guidance, was treated with 20 cc of the injection drug, consisting of 10 cc non-ionic contrast media Omnipaque 300; GE Healthcare (Carrigtwohill Co., Cork, Ireland) mixed with 0.5% lidocaine 10 cc containing 20 mg triamcinolone. Group B received fluoroscopically guided capsular distension with the same injection material. All patients received the procedure 3 times with 2 week intervals between treatments. Group A had additional radiological confirmation for proper intra-articular injection and evidence of capsular rupture.

### Injection method

In sono-guided capsular distension, the injection was performed using a posterolateral approach with Accuvix XQ® (Medison, Seoul, Korea) and a 6-12 MHz probe, with patients sitting up during treatment. Proper intra-articular injection was evaluated, with evidence of capsular distension by monitoring during the procedure followed by radiological exam ([Fig. 1](#F1){ref-type="fig"}).

In fluoroscopically guided capsular distension, the humeral head was captured with a C-arm (KOMED, Kwangju, Korea) adjusted in a cephalic-to-caudal angle, with patients in a prone position with a pillow underneath the affected shoulder. After aseptic preparation, a 22 gauge, 3.5 inch spinal needle Spinocan® (BRAUN, Melsungen, Germany) was placed superior to the anatomical neck of the humerus, and a solution containing non-ionic contrast media (Omnipaq) was injected under simultaneous fluoroscopic imaging ([Fig. 2](#F2){ref-type="fig"}).

All injection methods were performed by the same clinician, and no further physical therapy or medication was added. Only shoulder self-exercise prior to the procedures was permitted. Additionally, acetaminophen, with no anti-inflammatory effect, or ice massages were permitted if patients complained of pain at the injection site. Acetaminophen use during the follow-up period was also allowed.

### Evaluation of treatment efficacy

The evaluation was completed a total of three times, before the first injection followed by tests, and at the second and sixth weeks after completion of procedures. The degree of shoulder pain was graded with a visual numeric scale (VNS) with 1-cm increments between 0-10 cm. Functional disability was assessed by the \'Shoulder Pain and Disability Index\' (SPADI) proposed by Roach et al.[@B12] with scoring from 0 to 80, for which 0 represents absence of disability and point 10 represents severe disability that is in need of help for moving (in each of 8 categories). Range of motion in flexion, abduction, and external rotation was assessed both for passive and active movements. Flexion and abduction were examined in a supine position, with the main joint extended from the immobilized trunk using a 180-degree system. External rotation was examined with the shoulder joint abducted 90 degrees and the main joint flexed 90 degrees, as measured with a goniometer.

### Comparison in patient satisfaction, efficacy, time consumed, cost-effectiveness, and side effects

Data using patient questionnaires were collected by a doctor who had no knowledge of this study. Patients\' satisfaction levels after the completion of 3 injections during a 6 week period were expressed as \"excellent,\" \"good,\" \"fair,\" and \"poor\". Patients\' preference levels for the procedure were expressed in their answers to the question, \"Would you choose to receive the same procedure again after being informed of side effects and the pros and cons of each procedure?\" They could choose from:\"change,\" \"consider to change,\" \"not change,\" or \"neither\". The time the procedure took was calculated in seconds recorded in US and C-arm.

The cost-effectiveness of each method was calculated with expense spent to reduce pain severity (in this study expressed in VNS reduction). The difference between the two methods was calculated with the incremental cost-effective ratio (ICER), which measures the additional expense necessary for health gain of each unit as below:[@B13]

Cost is calculated with total cost of outpatient visits, and the procedure in Korean won, and effects with reduction by VNS scale. Complications before and after the procedure were also assessed.

Statistics
----------

We performed the student\'s t-test to compare differences in age, BMI, and disease duration between the two groups. Normality of the sample was confirmed, with a Shapiro-Wilk test performed prior to the student\'s t-test. Differences in sex, capsular rupture, and left and right lesions were calculated by the chi-square test. Comparisons of VNS, SPADI, and ROM between the two groups, at each period, were performed by Shapiro-Wilk test\'s normality testing and by a two-way repeated measures analysis of variance ANOVA. Bonferroni\'s correction was completed as the post-hoc test. Procedural preferences and satisfactory levels were analyzed with the chi-square test and procedural time with the student\'s t-test. Statistical analysis was processed using SAS Enterprise Guide 4.1 (4.1.0.471); the significant p-value was set below 0.05.

RESULTS
=======

General characteristics of patients
-----------------------------------

Group A was composed of 23 patients (6 males and 17 females) with a mean age of 56.04 years. The mean duration of disease among this group was 7.65 months. Group B was composed of 25 patients (8 males and 17 females) with a mean age of 56.36 and, among this group, the mean disease duration was 7.44 months. The general characteristics of patients did not differ significantly between the two groups (p\>0.05) ([Table 1](#T1){ref-type="table"}).

Change in pain severity by visual numeric scale
-----------------------------------------------

VNS before the procedure was 7.07±0.76 cm in group A and 6.92±0.61 cm in group B. VNS measured 2 weeks after the procedure was 2.84±0.66 cm and 3.09±0.52 cm for groups A and B respectively. Six weeks after the procedure, the measurements were 2.41±0.64 cm and 2.79±0.53 cm respectively, showing significant reduction in both groups. The degree of improvement and change in duration in the two groups showed no statistical differences (p\>0.05) ([Table 2](#T2){ref-type="table"}).

Change in shoulder pain and disability index
--------------------------------------------

SPADI before the procedure was 64.94±9.54 and 67.81±9.14 in groups A and B respectively. SPADI, measured 2 weeks after the final procedure, was 31.01±9.31 and 30.02±6.55. After 6 weeks, it was 29.25±8.33 and 27.83±6.79 for groups A and B respectively; this shows significant reduction in both groups. The degree of improvement and change over time, for both groups, showed no statistical differences (p\>0.05) ([Table 3](#T3){ref-type="table"}).

Change in articular range of motion in passive movements
--------------------------------------------------------

Passive range of motion, before and after the procedure, showed improvement for both groups and no statistical differences between the two groups (p\>0.05) ([Table 4](#T4){ref-type="table"}).

Change in articular range of motion in active movements
-------------------------------------------------------

Active range of motion before and after the procedure showed improvement for both groups and did not show statistical differences between the two groups (p\>0.05) ([Table 5](#T5){ref-type="table"}).

Comparison of effectiveness, preference, time interval, cost, and side effects
------------------------------------------------------------------------------

There were no significant differences in effectiveness between the two groups groups, but the preference levels among group A were higher than in group B (p\<0.05) ([Table 6](#T6){ref-type="table"}). The time interval in group A was 119.04±12.17 seconds, which was shorter than in group B, which was 294.08±24.30 (p\<0.05) ([Table 6](#T6){ref-type="table"}). Hot flush, as a side effect, was seen in 2 patients from each group, with no statistical differences between the two groups; no other side effects were reported.

The difference in VNS measured before the procedure and 6 weeks after it was Δ=4.58 and Δ=4.14 in groups A and B respectively ([Table 7](#T7){ref-type="table"}). The total cost of the procedure for group A was 184,284 Korean won and 283,210 Korean won in group B. The ICER was calculated as 224,831 won per VNS unit. Accordingly, group A\'s procedure cost less and showed superior outcomes. To acquire the treatment effect of VNS 0.44 units with sono-guided capsular distension, the cost was an additional 98,926 won, compared with the fluoroscopic-assisted method.

DISCUSSION
==========

The capsular distension method separates adherent synovium by hydropressure caused by injection of a large amount of fluid mixture. Since Salter had reported its effectiveness in 1970, it is widely used for its low cost, safety, and immediate effect in ROM, in patients with adhesive capsulitis.[@B14] Rizk et al.[@B6] explained that capsular distension shares a similar mechanism with manual reduction under anesthesia, and patients with no improvement after 3 months of conservative management should be treated.

Although controversy still exists regarding whether the primary pathology of adhesive capsulitis is inflammation or fibrosis, it is thought that its development is limited to the capsule with the synovial inner layer and synovial fluid.[@B15] Rodeo et al.[@B16] reported that cytokines such as Transforming Growth Factor-β (TGF-β) and Platelet-Derived Growth Factor (PDGF) play critical roles in the inflammatory reaction and fibrosis, and the differentiation process of fibroblasts was observed. Steroid injection was started as treatment based on the hypothesis that the main pathophysiology of capsulitis is an inflammatory response.

Neviaser[@B17] reported mild synovial inflammation accompanied by edema, vasodilation, and the deposition of mononuclear cells in some patients with adhesive capsulitis.

As inflammation also plays an important role in the process of synovial fibrosis, anti-inflammatory treatment is necessary for symptom improvement and prevention of further fibrosis. Thus, intracapsular steroid injection in adhesive capsulitis shows efficacy by reducing inflammatory response in the pathological process.[@B18] Additionally, if performed accurately, it produces faster pain control and ROM improvement with lower cost compared to conservative physiotherapy; thus, it has recently been widely used for outpatients.[@B19]-[@B21]

In 1989, Fareed and Gallivan[@B8] showed excellent efficacy of 40 ml steroid and saline mixture injection treatment, without individuals needing to be admitted to the hospital or needing to use arthroscope. Gam et al.[@B5] reported that patients who received capsular distension with steroids, via a US-guided posterior approach, showed more ROM improvement and reduced use of painkillers compared with patients who received intra-articular steroid injections. The initial mechanisms of hydraulic distension are capsular rupture and pressure-lowering by capsular volume extension, then anti-inflammatory effects produced by administration of steroid, local anesthetics, and contrast media.[@B6] In this study, additional steroid injection with capsular distension showed improvement in ROM, pain, and functional ability.

Several studies have investigated injection-targeting accuracy in blind trials. Yamakado[@B22] reported that, when evaluated with arthrography, targeting accuracy of reaching the subacromial bursa was judged to be about 70%. Partington and Broome.[@B23] reported the targeting accuracy to be about 83% in reaching the subacromial bursa and 60% in reaching the acromioclavicular joint with blind injection on cadavers. Erroneous decisions in diagnosis and treatment efficacy evaluation can be made with inaccurate injection. The US-guided and fluoroscopic methods used in this study can reduce such errors.

Diagnostic tools for adhesive capsulitis are: arthrography, magnetic resonance imaging (MRI), arthroscopy, and musculoskeletal ultra-sonography. Arthrography displays loss of axillary folds and biceps and reduction of articular volume below 10 ml. It is usually introduced as the examination of choice,[@B1],[@B24] but has the disadvantage of being too invasive to be easily clinically applicable; it also has diagnostic limitations in patients whose articular volume has not decreased below 10 ml. Additionally, the risk of radiological exposure to both patients and examiner is high. Additional radiological studies may be necessary in order to rule out other rotator cuff diseases.

Holsebeeck and Introcaso.[@B25] reported sonographic findings of adhesive capsulitis as continuous limitations of subacromial suprasinatus sliding movements in shoulder abduction and the lateral view of supraspinatus. Sonography enables diagnosis during direct monitoring of patients\' movements, without risk of radiological exposure. Furthermore, sonographic measurement of the coracohumeral ligament\'s thickness in the girdle band is useful in diagnosing adhesive capsulitis.[@B26]

In performing sonographic capsular distension, it was difficult to access the full view of the capsule, as in fluoroscopy. To compensate for this defect, distension was confirmed during drug injection, and an additional fluoroscopic exam using contrast media was performed in order to check the shoulder capsule following drug injection.

Efficacy for the two groups showed no statistical differences but with regard to preference, 24 patients (50%) of the total study population chose sonographic capsular distension and had higher preferences for it than fluoroscopic distension, which was chosen by only 6 patients (12.5%).

The main reason patients preferred sonographic distension was lack of radiological exposure. X-rays during fluoroscopic distension mean a type of ionizing radiation and have potent biological effects. Even a small amount can cause molecular damage and be carcinogenic in the future.[@B27] The International Commission of Radiological Protection estimates the annual maximal permissible dose on several organs and recommends that an examiner or patient not be exposed to more than 10% of the permissible dose.[@B28] The usual incidental skin dose during a one-minute fluoroscopic interventional procedure is 1-10 R (Roentgen) with a 2R per minute ray, equal to a radiological exposure of 130 times a chest radiograph, as an incidental skin dose of a typical chest X-ray is 15 mR (milliroentgen).[@B25] Thus, a procedure without risk of radiological exposure is preferred.

A total of 8 patients, 2 in group A and 6 in group B, refused both procedures because of pain during involved in them. As pain can reduce patients\' compliance to procedures, further studies ought to be performed in this field.

The limitations of this study were the small number of patients and the short (6-week) follow-up period. Enrollment criteria included patients of 1 and 2 grade adhesive capsulitis, with symptom duration lasting between 3 months and 2 years, but grade 3 patients could have been included for period overlap. Additionally, the cost was calculated for four different hospitals, for reliable results in evaluating cost-effectiveness. However, the part of the cost not covered by insurance differed among hospitals and was a limitation in analysis of cost-effectiveness. Even though individuals were examined by an expert with 5 years of experience in musculoskeletal ultrasonography and C-arm, the procedure time differences according to inter-examiners\' performance abilities remains a limitation.

A larger number of subjects, with a longer follow-up period comparing multiple methods of capsular distension, are needed in order to fully assess efficacy and cost-effectiveness in the future.

CONCLUSION
==========

In the comparison of sono-guided capsular distension with fluoroscopically guided capsular distension in adhesive capsulitis, results showed no statistical differences in ROM improvement and pain control. However, the sono-guided capsular distension method is preferred among patients due to lack of radiological exposure, lower cost, and faster procedure time.

![Sono-guided capsular distension. (A) Sono-guided capsular distension by the posterior lateral approach. (B) Before Sono-guided intra-articular injection at glenohumeral joint. (C) After sono-guided injection with capsular distension (arrow). The needle tip (arrowhead). (D) Shoulder posterior-anterior view. After steroid injection with capsular distension.](arm-36-88-g001){#F1}

![Fluoroscopically guided capsular distension. (A) Fluoroscopically guided capsular distension by the posterior approach. (B) Drawing shows patient in prone position for posterior approach. (C) Shoulder posterior-anterior view. The needle tip (arrow) was inserted above anatomical neck of humerus (D) Shoulder posterior-anterior view. After steroid injection with capsular distension.](arm-36-88-g002){#F2}

###### 

Characteristics of the Participants
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Values are mean±standard deviation

A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group
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Comparison of the Effect on VNS by the Capsular Distension
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Values are mean±standard deviation

VNS: Visual numeric scale, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group

^\*^p\<0.05: Comparison of before vs after injection, p\<0.05: Comparison of the A group vs B group
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Comparison of the Effect on SPADI by the Capsular Distension
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Values are mean±standard deviation

SPADI: Shoulder pain and Disability index, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group

^\*^p\<0.05: Comparison with the before injection
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Comparison of the Effect on Passive ROM by the Capsular Distension
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Values are mean±standard deviation

ROM: Range of Motion, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group

^\*^p\<0.05: Comparison of the before vs after the injection, p\<0.05: Comparison with the 2 week after the injection, p\<0.05: Comparison of the A group vs B group
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Comparison of the Effect on Active ROM by the Capsular Distension
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Values are mean±standard deviation

ROM: Range of Motion, A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group

^\*^p\<0.05: Comparison of before vs after injection, p\<0.05: Comparison with the 2 week after the injection, p\<0.05: Comparison of the A group vs B group
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Comparison of Effectiveness, Preference, Time Interval by the Capsular Distension
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Values are mean±standard deviation

A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group

###### 

Sono-guided Capsular Distension and Fluoroscopically Guided Capsular Distension Costs
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A group: Sono-guided capsular distension group, B group: Fluoroscopically guided capsular distension group
